Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Radical Improvement of Cancer Treatment without Additional Negative Side Effects

Project description

Personalised thermotherapy targets tumour hyperthermia

The Sensius systems offer unparalleled fulfillment in supporting solid tumor treatment with the use of thermotherapy in combination with radiation therapy, immunotherapy or chemotherapy. Sensius saves cancer patients from the dilemma between treatment and toxicity. This improves the balance in outcome and quality of life through personalised thermotherapy. The goal of the EU-funded HyperCollar4D project is to demonstrate the value of personalised thermotherapy, engaging the medical field to adopt it as adjuvant therapy for a range of different cancer types, starting with head and neck cancer to find the right balance between treatment outcome and quality of life for cancer patients.

Objective

We have developed a device called HyperCollar4D that significantly increases the effectiveness of radiotherapy for head and neck (H&N) cancer. The first results on 70 patients have proven that our technology yields +50% complete response with respect to radiotherapy alone. The HyperCollar4D is based on hyperthermia: warming up the tumor to 43 C improves its sensitivity to radiotherapy. Hyperthermia yields no lasting toxicity, unlike radiotherapy and chemotherapy. The challenge with hyperthermia is delivering it effectively (i.e. heating only the tumor and not the nearby tissues) and cost-efficiently. The HyperCollar4D is the first device to achieve effective and cost-efficient hyperthermia treatments for H&N cancer. Our technology (called thermotherapy) is protected by two patents (one granted and one filed). The HyperCollar4D design is modular, so it can be extended to add modules to treat other kinds of cancers. Sensius is a spin-off of the Erasmus Medical Center.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2021-ACCELERATORCHALLENGES-01

See all projects funded under this call

Coordinator

SENSIUS BV
Net EU contribution
€ 2 500 000,00
Address
DR MOLEWATERPLEIN 40 UNIT BA589
3015 GD Rotterdam
Netherlands
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 8 574 256,00